ReachMD: The importance of extended genotyping in cervical cancer screening: The special case of HPV 31

Could an HPV test with extended genotyping that can individually identify HPV 16, 18, 31, and other genotypes change the way we manage cervical cancer screening results?

In this video, Dr. Mark Stoler, Professor of Pathology and Clinical Gynecology at the University of Virginia Health System, discusses the special case of HPV 31.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Contemporary Obgyn: Not all HPV genotypes pose the same risk for disease
Cervical Cancer | News & Updates
Contemporary OB/GYN: Not all HPV genotypes pose the same risk for disease
Smiling woman smiling while painting
STIs | Vaginitis | Brochures
Vaginitis and STIs: The right treatment begins with the right diagnosis
BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay
Cervical Cancer | News & Updates
Press release: BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay